INJECTABLES/ IV/INFUSION
BrewXONEâ„¢ TZ 1.125
Ceftriaxone 1gm + Tazobactum 125mg
Dosage Form
Dry Injection
Packing
1 Vial
MRP
₹195
Prescribed By
General Medicine, Infectious Disease, Pulmonology
Quick Facts
Form
Dry Injection
Pack
1 Vial
MRP
Rs.195
Prescribed By
General Medicine, Infectious Disease, Pulmonology
Key Benefits
01
Tazobactam is a more potent beta-lactamase inhibitor than Sulbactam.
02
Effective against ESBL-producing organisms.
03
Combination extends Ceftriaxone's spectrum significantly.
04
Useful for resistant infections in hospital settings.
Mechanism of Action
Ceftriaxone provides broad-spectrum cephalosporin activity. Tazobactam is a potent beta-lactamase inhibitor that protects Ceftriaxone from beta-lactamase-producing resistant bacteria, including ESBL-producing organisms.
Indications
ESBL-producing bacterial infections, resistant hospital-acquired infections, serious polymicrobial infections.
Dosage & Administration
Take as prescribed by your doctor or healthcare professional. Do not self-medicate.
Why BrewXONEâ„¢ TZ 1.125?
BrewXONE TZ 1.125 uses the more potent Tazobactam inhibitor alongside Ceftriaxone — providing superior coverage against ESBL-producing and other resistant organisms compared to Sulbactam combinations.
